|
Drug Therapy
Citations 121-130 of 200 total displayed.
|
Past content
(since May 1999):
|
- Observations
Delayed Allergic Reaction to Natalizumab Associated With Early Formation of Neutralizing Antibodies
- Markus Krumbholz; Hannah Pellkofer; Ralf Gold; Lisa Ann Hoffmann; Reinhard Hohlfeld; Tania Kümpfel
Arch Neurol 2007; 64: 1331-1333.
[Abstract]
[Full text]
[PDF]
- Observations
Lamotrigine Intoxication Provoking Status Epilepticus in an Adult With Localization-Related Epilepsy
- Eric Dinnerstein; Barbara C. Jobst; Peter D. Williamson
Arch Neurol 2007; 64: 1344-1346.
[Abstract]
[Full text]
[PDF]
- Neurological Reviews
Treatment Options in the Modern Management of Parkinson Disease
- Anthony H. V. Schapira
Arch Neurol 2007; 64: 1083-1088.
[Extract]
[Full text]
[PDF]
- Neurological Reviews
Medication-Related Impulse Control and Repetitive Behaviors in Parkinson Disease
- Valerie Voon; Susan H. Fox
Arch Neurol 2007; 64: 1089-1096.
[Abstract]
[Full text]
[PDF]
- Clinical Trials
Randomized, Double-blind, Placebo-Controlled Trial on Symptomatic Effects of Coenzyme Q10 in Parkinson Disease
- Alexander Storch; Wolfgang H. Jost; Peter Vieregge; Jörg Spiegel; Wolfgang Greulich; Joachim Durner; Thomas Müller; Andreas Kupsch; Henning Henningsen; Wolfgang H. Oertel; Gerd Fuchs; Wilfried Kuhn; Petra Niklowitz; Rainer Koch; Birgit Herting; Heinz Reichmann; for the German Coenzyme Q10 Study Group
Arch Neurol 2007; 64: 938-944.
[Abstract]
[Full text]
[PDF]
- Clinical Trials
Safety, Tolerability, and Pharmacokinetics of High-Dose Idebenone in Patients With Friedreich Ataxia
- Nicholas A. Di Prospero; Charlotte J. Sumner; Scott R. Penzak; Bernard Ravina; Kenneth H. Fischbeck; J. Paul Taylor
Arch Neurol 2007; 64: 803-808.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Risk Factors for the Development of Pedal Edema in Patients Using Pramipexole
- Galit Kleiner-Fisman; David N. Fisman
Arch Neurol 2007; 64: 820-824.
[Abstract]
[Full text]
[PDF]
- Observations
Multiple Ischemic Strokes Associated With Use of Recombinant Activated Factor VII
- Richard B. Libman; Cordrin Lungu; Thomas Kwiatkowski
Arch Neurol 2007; 64: 879-881.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Transdermal Rotigotine: Double-blind, Placebo-Controlled Trial in Parkinson Disease
- Joseph Jankovic; Ray L. Watts; Wayne Martin; Babak Boroojerdi; for the SP 512 Rotigotine Transdermal System Clinical Study Group
Arch Neurol 2007; 64: 676-682.
[Abstract]
[Full text]
[PDF]
[ Notice of Redundant Publication ]
- Original Contributions
Testosterone Treatment in Multiple Sclerosis: A Pilot Study
- Nancy L. Sicotte; Barbara S. Giesser; Vinita Tandon; Ricki Klutch; Barbara Steiner; Ann E. Drain; David W. Shattuck; Laura Hull; He-Jing Wang; Robert M. Elashoff; Ronald S. Swerdloff; Rhonda R. Voskuhl
Arch Neurol 2007; 64: 683-688.
[Abstract]
[Full text]
[PDF]
|
|